The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and feasibility of adding tumor debulking to palliative chemotherapy in multi-organ metastatic colorectal cancer: The ORCHESTRA trial.
 
Elske C. Gootjes
No Relationships to Disclose
 
Eric P. van der Stok
No Relationships to Disclose
 
Lotte Bakkerus
No Relationships to Disclose
 
Tineke E Buffart
No Relationships to Disclose
 
Barbara M Zonderhuis
No Relationships to Disclose
 
Martijn R. Meijerink
No Relationships to Disclose
 
Cornelis J Haasbeek
No Relationships to Disclose
 
Peter M van de Ven
No Relationships to Disclose
 
Albert J. Ten Tije
No Relationships to Disclose
 
Jan Willem De Groot
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Celgene; MSD; SERVIER
 
Sandra A Radema
No Relationships to Disclose
 
Esther Van Meerten
Consulting or Advisory Role - Bristol-Myers Squibb; Merck
Research Funding - AstraZeneca (Inst)
 
Joost Nuyttens
No Relationships to Disclose
 
Cornelis Verhoef
No Relationships to Disclose
 
Henk M.W. Verheul
Consulting or Advisory Role - Boehringer Ingelheim (Inst); Merck (Inst); Pfizer (Inst)
Research Funding - Amgen (Inst); Immunovo (Inst); Novartis (Inst); Roche (Inst); Vitromics (Inst)